Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.61

+5.2%

Nov 6 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (13312)	10/5/2004 1:08:00 PM
From: fred hayes	Read Replies (1) of 52153

Peter: Agreed that this makes MEDI look more attractive, but a simpler approach may be CHIR at a 20 percent discount. I don't follow the company closely, but I can't see it being worth 20 percent less today than yesterday because of a one-year flu vaccine problem. And I'm wondering whether the problem could still be resolved for this year. I wonder if this could be some kind of brinkmanship play to put on pressure to resolve the issues rather than a final decision that precludes vaccine for this season. I stress that I have no idea of the answer... fred

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next